OptiNose Stock Price

-0.19 (-5.37%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
OptiNose Inc OPTN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.19 -5.37% 3.35 18:32:59
Close Price Low Price High Price Open Price Previous Close
3.35 3.33 3.54 3.50 3.54
Bid Price Ask Price Spread News
3.16 3.82 0.66 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,425 376,133 $ 3.42 $ 1,286,456 355,477 3.15 - 11.66
Last Trade Time Type Quantity Stock Price Currency
18:32:59 10 $ 3.38 USD

OptiNose Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 174.17M 51.99M 29.78M $ 34.63M $ - -2.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 34.46k 1.40%

more financials information »

OptiNose News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OPTN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.814.253.153.65576,529-0.46-12.07%
1 Month3.894.253.153.79286,753-0.54-13.88%
3 Months6.,609-2.82-45.71%
6 Months4.1810.003.155.23492,710-0.83-19.86%
1 Year7.4211.663.155.85385,802-4.07-54.85%
3 Years20.0230.003.159.48262,570-16.67-83.27%
5 Years20.0030.003.159.79267,429-16.65-83.25%

OptiNose Description

OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhalation delivery system, to deliver a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.